Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $1.51B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 9,066,621 | $446M | 29.5% | $49.16 * | $29.98 | +51.7% | COM | 80706P103 |
| KRYS | KRYSTAL BIOTECH INC | 673,505 | $174M | 11.5% | $258.32 * | $62.38 | +336.7% | COM | 501147102 |
| STOK | STOKE THERAPEUTICS INC | 4,164,120 | $136M | 9.0% | $32.56 * | $9.71 | +227.8% | COM | 86150R107 |
| IMNM | IMMUNOME INC | 5,558,885 | $122M | 8.1% | $21.87 * | $11.49 | +100.8% | COM | 45257U108 |
| NRIX | NURIX THERAPEUTICS INC | 7,732,808 | $120M | 7.9% | $15.50 * | $17.18 | +0.9% | COM | 67080M103 |
| ANNX | ANNEXON INC | 14,549,768 | $80.61M | 5.3% | $5.54 * | $8.54 | -32.7% | COM | 03589W102 |
| ADCT | ADC THERAPEUTICS SA | 15,470,502 | $58.01M | 3.8% | $3.75 * | $19.52 | -80.4% | SHS | H0036K147 |
| RGNX | REGENXBIO INC | 4,368,804 | $36.61M | 2.4% | $8.38 * | $22.74 | -49.0% | COM | 75901B107 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $35.62M | 2.4% | $6.43 * | $32.14 | -87.1% | COM | 82024L103 |
| BEAM | BEAM THERAPEUTICS INC | 1,237,659 | $29.49M | 2.0% | $23.83 * | $26.47 | +10.2% | COM | 07373V105 |
| NGNE | NEUROGENE INC | 1,459,599 | $29.43M | 1.9% | $20.16 * | $22.00 | -17.5% | COM | 64135M105 |
| COGT | COGENT BIOSCIENCES INC | 688,036 | $26.48M | 1.8% | $38.49 * | $9.95 | +275.5% | COM | 19240Q201 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $24.76M | 1.6% | $3.00 | $19.01 | -84.2% | COM | 00091E109 |
| IDYA | IDEAYA BIOSCIENCES INC | 521,117 | $17.36M | 1.1% | $33.32 | $27.49 | +23.2% | COM | 45166A102 |
| ALXO | ALX ONCOLOGY HLDGS INC | 7,964,188 | $15.97M | 1.1% | $2.01 * | $7.38 | -76.0% | COM | 00166B105 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $15.45M | 1.0% | $1.20 | $13.12 | -90.8% | COM | 31189P102 |
| XENE | XENON PHARMACEUTICALS INC | 262,674 | $15.27M | 1.0% | $58.15 * | $41.99 | -0.0% | COM | 98420N105 |
| SLDB | SOLID BIOSCIENCES INC | 2,011,895 | $14.49M | 1.0% | $7.20 * | $4.76 | +27.2% | COM NEW | 83422E204 |
| NUVB | NUVATION BIO INC | 3,153,256 | $13.53M | 0.9% | $4.29 * | $10.97 | -43.6% | COM CL A | 67080N101 |
| ZYME | ZYMEWORKS INC | 491,654 | $12.31M | 0.8% | $25.04 * | $7.05 | +231.7% | COM | 98985Y108 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $11.41M | 0.8% | $5.27 | $18.53 | — | ADS | 82686Q101 |
| DBVT | DBV TECHNOLOGIES S A | 491,340 | $10.26M | 0.7% | $20.89 | $19.17 | — | SPONSORED ADS | 23306J309 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 173,859 | $9.821M | 0.7% | $56.49 * | $58.72 | 0.0% | COM | 09061G101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 261,508 | $8.295M | 0.5% | $31.72 * | $11.60 | +119.2% | COM NEW | 15117B202 |
| CBLL | CERIBELL INC | 386,786 | $7.09M | 0.5% | $18.33 * | $27.25 | -22.6% | COM | 15678C102 |
| LIVN | LIVANOVA PLC | 108,354 | $6.887M | 0.5% | $63.56 * | $70.40 | -7.5% | SHS | G5509L101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 103,464 | $5.875M | 0.4% | $56.78 * | $44.21 | +59.1% | COM | G31249108 |
| PRME | PRIME MEDICINE INC | 1,590,832 | $5.536M | 0.4% | $3.48 * | $3.80 | 0.0% | COM | 74168J101 |
| ORIC | ORIC PHARMACEUTICALS INC | 415,710 | $5.267M | 0.3% | $12.67 * | $11.51 | -6.5% | COM | 68622P109 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 700,000 | $5.068M | 0.3% | $7.24 * | $8.37 | 0.0% | COM | 29842P105 |
| ARDX | ARDELYX INC | 733,350 | $4.393M | 0.3% | $5.99 * | $7.08 | 0.0% | COM | 039697107 |
| IVVD | INVIVYD INC | 2,648,659 | $3.443M | 0.2% | $1.30 * | $16.17 | -87.8% | COM | 00534A102 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $2.089M | 0.1% | $4.73 * | $15.04 | -56.2% | COM NEW | 046513206 |
| AGMB | AGOMAB THERAPEUTICS NV | 156,250 | $1.639M | 0.1% | $10.49 | $10.49 | — | SPONSORED ADS | 00860C102 |
| PLRX | PLIANT THERAPEUTICS INC | 772,126 | $973K | 0.1% | $1.26 | $22.50 | -94.5% | COM | 729139105 |